Serina Therapeutics (SER) EBIT Margin Growth (1y) (2019 - 2025)
Serina Therapeutics (SER) EBIT Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | -1,651.00 |
| 10 | Serina Therapeutics | 44.24 Mn | 21.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 329,962.00 |
| Dec 31, 2024 | 3.96 Mn |
| Sep 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | 591,961.00 |
| Mar 31, 2024 | -4.32 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | -24,167.00 |
| Mar 31, 2023 | 3.78 Mn |
| Dec 31, 2022 | -2.11 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -729,887.00 |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | 30,591.00 |
| Sep 30, 2021 | -350,109.00 |
| Jun 30, 2021 | -69,724.00 |
| Mar 31, 2021 | -52,558.00 |
| Dec 31, 2020 | -97,807.00 |
| Sep 30, 2020 | -267,610.00 |
| Jun 30, 2020 | -435,643.00 |